4056
J. Med. Chem. 2002, 45, 4056
Additions and Corrections 2001, Volume 44
2002, Volume 45
Michael J. Robarge, Stephen M. Husbands, Andrzej Kieltyka, Robbin Brodbeck, Andrew Thurkauf, and Amy Hauck Newman*: Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D3 Receptor Subtype.
Bastiaan J. Venhuis, Nienke Rodenhuis, Håkan V. Wikstro1 m,* David Wustrow, Leonard T. Meltzer, Lawrence D. Wise, Stephen J. Johnson, Thomas A. Pugsley, Staffan Sundell, and Durk Dijkstra: A New Type of Prodrug of Catecholamines: An Opportunity To Improve the Treatment of Parkinson’s Disease.
Page 3178. The structures for 58a and 58b were incorrect. The correct structures are shown below.
Page 2349. The author list and the address line have been modified. The correct list of authors with their affiliations are listed below. Bastiaan J. Venhuis,† Nienke Rodenhuis,† Håkan V. Wikstro¨m,*,† David Wustrow,‡ Leonard T. Meltzer,‡ Lawrence D. Wise,‡ Stephen J. Johnson,‡ Thomas A. Pugsley,‡ Staffan Sundell,§ and Durk Dijkstra†
Page 3180. There is an error in line 15. The correct statement is the following. The position of the amidelinkage on the fluorenyl ring appears to be optimal at either the 2- or 4-positions, as seen with 58b and 51, respectively. JM020255I 10.1021/jm020255i Published on Web 07/30/2002
Department of Medicinal Chemistry, University Centre for Pharmacy, University of Groningen, Antonius Deusinglaan 1, NL-9713 AV Groningen, The Netherlands, CNS Chemistry and Pharmacology, Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48105, and Department of Medical Biochemistry, University of Go¨ teborg, Box 440, SE-405 30 Go¨ teborg, Sweden * Correspondence and requests for materials should be addressed to H. V. Wikstro¨m (e-mail:
[email protected]). † University of Groningen. ‡ Pfizer Global Research and Development. § University of Go ¨ teborg.
JM0209634 10.1021/jm0209634 Published on Web 07/18/2002
